comparemela.com
  1. Home
  2. Live Updates
  3. Clinical Oncology - Breaking News

Latest Breaking News On - Clinical oncology - Page 20 : comparemela.com

ASCO24: Tagrisso in the spotlight, Caribou s adjustment and Lilly s KRAS competitor

BioPharma

United statesUs eli lillyJonathan gardnerNed pagliaruloDaiichi sankyo enhertuBristol myers squibbAmerican society of clinical oncologyBiopharma diveAmerican societyClinical oncologyDaiichi sankyoCaribou biosciences

Personalised skin cancer vaccine being trialled on NHS could halve the risk of death or relapse, study finds

A PIONEERING skin cancer vaccine being trialled on the NHS could halve the risk of death or relapse, according to a study.It is an early boost for the

United kingdomUnited statesHeather shawPeter johnsonSteve youngCharles swantonSam blanchardJeffrey weberCancer research united kingdomHealth correspondentAmerican society of clinical oncologyYork universityUniversity of viennaCancer vaccines launch padNew york universityAmerican society

Ascendis Pharma Presents New Data and Updated Results from Phase 1/2 IL-Believe Trial at ASCO 2024

-  40% of efficacy-evaluable patients (2 out of 5) in the initial cohort of patients with anti-PD-1 refractory melanoma treated with TransCon IL-2.

United statesChicago mayStina singelMelinda bakerAscendis pharmaTim leeHead of clinical developmentExchange commissionPatti bankAmerican society of clinical oncologyBelieve trialAmerican societyClinical oncologyExecutive vice presidentClinical developmentAscendi annual report

Brain trust? Agios PDUFA near, Pyrukynd strong in thalassemia

Brain trust? Agios PDUFA near, Pyrukynd strong in thalassemia
bioworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bioworld.com Daily Mail and Mail on Sunday newspapers.

United statesMedicenna therapeutics corpAmerican society of clinical oncologyWhile agios pharmaceuticals incWhile agios pharmaceuticalsAmerican societyClinical oncology

Innovative liquid biopsy blood test detects breast cancer relapse early on

New ultra-sensitive blood test can accurately predict breast cancer recurrence up to 41 months before relapse confirmed by detecting circulating tumor DNA, potentially improving survival rates for patients

United statesAmerican society of clinical oncologyAmerican societyClinical oncology

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.